These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 19702900)

  • 1. Alterations of Mast Cells in the Esophageal Mucosa of the Patients With Non-Erosive Reflux Disease.
    Yu Y; Ding X; Wang Q; Xie L; Hu W; Chen K
    Gastroenterology Res; 2011 Apr; 4(2):70-75. PubMed ID: 27942317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of prokinetics to PPI therapy in gastroesophageal reflux disease: a meta-analysis.
    Ren LH; Chen WX; Qian LJ; Li S; Gu M; Shi RH
    World J Gastroenterol; 2014 Mar; 20(9):2412-9. PubMed ID: 24605040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitor for non-erosive reflux disease: a meta-analysis.
    Zhang JX; Ji MY; Song J; Lei HB; Qiu S; Wang J; Ai MH; Wang J; Lv XG; Yang ZR; Dong WG
    World J Gastroenterol; 2013 Dec; 19(45):8408-19. PubMed ID: 24363534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study on the efficacy of rebamipide for patients with proton pump inhibitor-refractory non-erosive reflux disease.
    Adachi K; Furuta K; Miwa H; Oshima T; Miki M; Komazawa Y; Iwakiri K; Furuta T; Koike T; Shimatani T; Kinoshita Y
    Dig Dis Sci; 2012 Jun; 57(6):1609-17. PubMed ID: 22367114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in health-related quality of life after therapy with omeprazole in patients with coronary artery disease and recurrent angina-like chest pain. A double-blind, placebo-controlled trial of the SF-36 survey.
    Budzyński J; Pulkowski G; Suppan K; Fabisiak J; Majer M; Kłopocka M; Galus-Pulkowska B; Wasielewski M
    Health Qual Life Outcomes; 2011 Sep; 9():77. PubMed ID: 21939510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pain system in oesophageal disorders: mechanisms, clinical characteristics, and treatment.
    Lottrup C; Olesen SS; Drewes AM
    Gastroenterol Res Pract; 2011; 2011():910420. PubMed ID: 21826137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPI therapy is equally effective in well-defined non-erosive reflux disease and in reflux esophagitis: a meta-analysis.
    Weijenborg PW; Cremonini F; Smout AJ; Bredenoord AJ
    Neurogastroenterol Motil; 2012 Aug; 24(8):747-57, e350. PubMed ID: 22309489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of risk factors and clinical responses to proton pump inhibitors in patients with erosive oesophagitis and non-erosive reflux disease.
    Lee ES; Kim N; Lee SH; Park YS; Kim JW; Jeong SH; Lee DH; Jung HC; Song IS
    Aliment Pharmacol Ther; 2009 Jul; 30(2):154-64. PubMed ID: 19392871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastro-oesophageal reflux disease and Helicobacter pylori or gastro-oesophageal reflux disease from Helicobacter pylori?
    Lundell L
    Eur J Gastroenterol Hepatol; 2001 May; 13 Suppl 1():S23-7. PubMed ID: 11430505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant irritable bowel syndrome is associated with failure of step-down on-demand proton pump inhibitor treatment in patients with gastro-esophageal reflux disease.
    Wu JC; Lai LH; Chow DK; Wong GL; Sung JJ; Chan FK
    Neurogastroenterol Motil; 2011 Feb; 23(2):155-60, e31. PubMed ID: 21087355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic trends of diseases of the upper gastrointestinal tract in patients with negative H. pylori status].
    Watari J; Sakurai J; Morita T; Oshima T; Hori K; Miwa H
    Nihon Rinsho; 2009 Dec; 67(12):2378-86. PubMed ID: 19999128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis used to identify factors associated with the effectiveness of proton pump inhibitors against non-erosive reflux disease.
    Hiyama T; Matsuo K; Urabe Y; Fukuhara T; Tanaka S; Yoshihara M; Haruma K; Chayama K
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1326-32. PubMed ID: 19702900
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.